It has also been demonstrated that SIRT1 activators, such as cytarabine and resveratrol, may attenuate the development of cytokine storms and alleviate hyperinflammation and neuroinflammation-mediated cognitive dysfunction in COVID-19 patients (54). This evidence concerns the gene SIRT1 and COVID-19.